Cancer Facts and Figs (2025) (American Cancer Society, Atlanta.

Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12–49

PubMed  Google Scholar 

Park M et al (2022) Breast Cancer metastasis: mechanisms and therapeutic implications. Int J Mol Sci 23

Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018) Brain metastases: epidemiology. Handb Clin Neurol 149:27–42

Article  PubMed  Google Scholar 

Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 5:28

Article  PubMed  PubMed Central  Google Scholar 

Suh JH et al (2020) Current approaches to the management of brain metastases. Nat Rev Clin Oncol 17:279–299

Article  PubMed  Google Scholar 

Waks AG, Winer EP (2019) Breast Cancer Treatment: A Review. JAMA 321:288–300

Article  CAS  PubMed  Google Scholar 

Lin NU et al (2020) Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial. J Clin Oncol 38:2610–2619

Article  CAS  PubMed  PubMed Central  Google Scholar 

Modi S et al (2020) Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer. N Engl J Med 382:610–621

Article  CAS  PubMed  Google Scholar 

Castaneda CA et al (2015) Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer. CNS Oncol 4:137–145

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leone JP, Lee AV, Brufsky AM (2015) Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy. Cancer Med 4:989–994

Article  PubMed  PubMed Central  Google Scholar 

Witzel I et al (2018) Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry. Eur J Cancer 102:1–9

Article  CAS  PubMed  Google Scholar 

Hohensee I et al (2017) PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression. Oncotarget 8:6155–6168

Article  PubMed  PubMed Central  Google Scholar 

Yin L, Duan JJ, Bian XW, Yu SC (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 22:61

Article  PubMed  PubMed Central  Google Scholar 

Meric-Bernstam F et al (2018) Survival outcomes by TP53 mutation status in metastatic breast cancer. JCO Precis Oncol

Batalini F et al (2020) Response of brain metastases from PIK3CA-mutant breast cancer to alpelisib. JCO Precis Oncol 4

Giannoudis A et al (2024) Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors. NPJ Precis Oncol 8:282

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:e173–180

Article  PubMed  PubMed Central  Google Scholar 

Gittleman H et al (2019) An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival. Neurooncol Adv 1:vdz007

PubMed  PubMed Central  Google Scholar 

Huang B et al (2024) Development and validation of a nomogram based on Lasso-Logistic regression for predicting splenomegaly secondary to acute pancreatitis. BMC Gastroenterol 24:281

Article  PubMed  PubMed Central  Google Scholar 

Xie W, Li Y, Meng X, Zhao M (2023) Machine learning prediction models and nomogram to predict the risk of in-hospital death for severe DKA: A clinical study based on MIMIC-IV, eICU databases, and a college hospital ICU. Int J Med Inf 174:105049

Article  Google Scholar 

Huang T, Yan T, Chen G, Zhang C (2021) Development and Validation of a Gene Mutation-Associated Nomogram for Hepatocellular Carcinoma Patients From Four Countries. Front Genet 12:714639

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nassiri F et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol 21:901–910

Article  CAS  PubMed  PubMed Central  Google Scholar 

Consortium APG, AACR Project GENIE (2017) Powering Precision Medicine through an International Consortium. Cancer Discov 7:818–831

Article  Google Scholar 

Lavery JA et al (2022) A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative Approach. JCO Clin Cancer Inf 6:e2100105

Google Scholar 

Project AACR GENIE 16.0-public Data guide. (AACR)

Lavery JA et al (2023) A data processing pipeline for the AACR project GENIE biopharma collaborative data with the genieBPC R package. Bioinformatics 39

Whiting K, Curry M, Fuchs H, Martin A, Arora A gnomeR: Wrangle and analyze IMPACT and TCGA mutation data

Sanz-Garcia E et al (2024) Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry. Cancer Res Commun 4:475–486

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sondhi A (2022) Estimating survival parameters under conditionally independent left truncation. Pharm Stat 21:895–906

Article  PubMed  PubMed Central  Google Scholar 

Friedman J et al (2023), CRAN,. glmnet: lasso and elastic-net regularized generalized linear models, version 4.1-8.

Karrison T, Kocherginsky M (2018) Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials? Clin Trials 15:178–188

Article  PubMed  PubMed Central  Google Scholar 

Gerds TA et al (2023), riskRegression: risk regression models and prediction scores for survival analysis with competing risks.

Zhang Z et al (2018) Overview of model validation for survival regression model with competing risks using melanoma study data. Ann Transl Med 6:325

Article  PubMed  PubMed Central  Google Scholar 

Gerds TA, Andersen PK, Kattan MW (2014) Calibration plots for risk prediction models in the presence of competing risks. Stat Med 33:3191–3203

Article  PubMed  Google Scholar 

Gerds TA, Cai T, Schumacher M (2008) The performance of risk prediction models. Biom J 50:457–479

Article  PubMed  Google Scholar 

Harrell FE (2024) rms: regression modeling strategies

Zhicheng D, Hao Y, (2017) NomogramEx: extract equations from a nomogram

Tommasi C et al (2024) Hormone receptor-positive/HER2-positive breast cancer: hormone therapy and anti-HER2 treatment: an update on treatment strategies. J Clin Med 13

Derakhshan F, Reis-Filho JS (2022) Pathogenesis of Triple-Negative Breast Cancer. Annu Rev Pathol 17:181–204

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howard FM, Olopade OI (2021) Epidemiology of Triple-Negative Breast Cancer: A Review. Cancer J 27:8–16

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Q et al (2021) NCCBM, a Nomogram Prognostic Model in Breast Cancer Patients With Brain Metastasis. Front Oncol 11:642677

Article  PubMed  PubMed Central  Google Scholar 

Cheng X, Zhao JX, Dong F, Cao XC (2021) ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target. Front Oncol 11:759577

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rivera DR et al (2022) The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies. Clin Pharmacol Ther 111:283–292